Application
Antibodies tested include p-Rsk (C-5): (A,B,C) and Ribosomal Rsk-1 (C-21): (D,E,F).
Application
Antibodies tested include p-Rsk (Thr 359/Ser 363)-R: (A,B,C) and Rsk-1 (C-21): (D,E,F).
Application
Antibodies tested include p-Rsk (Ser 227)-R: (A,B,C) and Rsk-1 (C-21): (D,E,F).
Application
Antibodies tested include p-Rsk-1/2/4 (Ser 363)-R: (A,B,C) and Rsk-1 (C-21): (D,E,F).
Application
Antibodies tested include p-Rsk (Ser 380)-R: (A,B,C) and Rsk-1 (C-21): (D,E,F).
Application
Antibodies tested include p-Rsk (Ser 227)-R: (A,B) and Rsk-1 (C-21): (C,D).
Application
Intracellular FCM analysis of fixed and permeabilized HeLa cells. Black line histogram represents the isotype control, normal rabbit IgG: .
Application
Intracellular FCM analysis of fixed and permeabilized HeLa cells. Black line histogram represents the isotype control, normal rabbit IgG: .
Application
Blots were probed with p-Rsk-1/2/4 (Ser 363)-R: preincubated with cognate phosphorylated (A) and unphosphorylated (B) peptide and Rsk-1 (C-21): (C).
Application
Cytoplasmic immunofluorescence staining of methanol-fixed NIH/3T3 cells.
Application
Antibodies tested include Rsk-1 (C-21): (A-E) and Rsk-1 (C-21)-G: (F-J).
Application
Antibodies tested include Rsk-1 (C-21): (A,B), p-Rsk (Ser 376): (C,D) and p-Rsk (Ser 376)-R: (E,F).
Application
Antibodies tested include Rsk-1 (C-21): (A,B) and p-Rsk-1/2 (Thr 359/Ser 363)-R: (C,D).